Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing flurazepam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental flurazepam poisoning |
Causative agent (attribute) |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional flurazepam poisoning |
Causative agent (attribute) |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le flurazépam d'intention indéterminée |
Causative agent (attribute) |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam adverse reaction |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to flurazepam (finding) |
Causative agent (attribute) |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flurazepam overdose |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental flurazepam overdose (disorder) |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional flurazepam overdose (disorder) |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de flurazépam d'intention indéterminée |
Causative agent (attribute) |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by flurazepam |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam hydrochloride 15mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flurazepam hydrochloride 30mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flurazepam measurement |
Component |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flurazepam (as flurazepam hydrochloride) 15 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely flurazepam (as flurazepam hydrochloride) 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional flurazepam poisoning |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam hydrochloride |
Is a |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental poisoning by flurazepam |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of mass concentration of flurazepam in urine specimen (procedure) |
Component |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of substance concentration of flurazepam in serum or plasma specimen (procedure) |
Component |
False |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to flurazepam (finding) |
Causative agent (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flurazepam (as flurazepam hydrochloride) 15 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely flurazepam (as flurazepam hydrochloride) 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam hydrochloride |
Is modification of (attribute) |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flurazepam-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Flurazepam only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of mass concentration of flurazepam in urine specimen (procedure) |
Component |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of mass concentration of flurazepam and flurazepam metabolite in serum or plasma specimen (procedure) |
Component |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of substance concentration of flurazepam in serum or plasma specimen (procedure) |
Component |
True |
Flurazepam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |